Cited by 1,063Receptor Mechanisms and SignalingNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

Open access

Jeffrey Conn, P., Christopoulos, Arthur, Lindsley, Craig W.·2009·Nature Reviews Drug Discovery

DOI 10.1038/nrd2760PMC PMC2907734

Open this paper in CoChat — free account

Abstract

Despite G-protein-coupled receptors (GPCRs) being among the most fruitful targets for marketed drugs, intense discovery efforts for several GPCR subtypes have failed to deliver selective drug candidates. Historically, drug discovery programmes for GPCR ligands have been dominated by efforts to develop agonists and antagonists that act at orthosteric sites for endogenous ligands. However, in recent years, there have been tremendous advances in the discovery of novel ligands for GPCRs that act at allosteric sites to regulate receptor function. These compounds provide high selectivity, novel modes of efficacy and may lead to novel therapeutic agents for the treatment of multiple psychiatric and neurological human disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrd2760

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
Conn, P. J., & Pin, J. (1997) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.205 · Cited by 3,083
The Ecology of Freshwater Phytoplankton.
Jones, R. I., & REYNOLDS, C. S. (1985) · Journal of Ecology · doi:10.2307/2260522 · Cited by 2,817
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580
G Protein-coupled Receptors
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,281
Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity
Dorr, P. K., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M. J., Mori, J., Rickett, G., Smith‐Burchnell, C., Napier, C. M., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4721-4732.2005 · Cited by 1,154
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B. K., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,131
Self-citation
Operational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 1,106
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006

Show all 139 references

Research works printed but not linked: 2

Swanson, C. J., Bures, M., Johnson, M. P., Linden, A. M., Monn, J. A. & Schoepp, D. D. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nature Rev. Drug Discov. 4, 131–144 (2005). · DOI · Paper page
Baez, M. et al. Molecular mapping of a subtype selective site for positive allosteric modulation of the mGlu2 receptor. Neuropharmacol. Abstr. 43, 274–275 (2002).

Sorted by citations

Items 901–1,000 of 1,000

Multiplexing Label-Free and Fluorescence-Based Methods for Pharmacological Characterization of GPCR Ligands
Zhong, H., Huang, X., & Doller, D. (2015) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-2617-6_12 · Cited by 2
Live Cell Bioluminescence Imaging in Temporal Reaction of G Protein-Coupled Receptor for High-Throughput Screening and Analysis
Hattori, M., & Ozawa, T. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3813-1_16 · Cited by 2
Acetylcholine and Muscarinic Receptors
Brown, J. H., & Laiken, N. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-386525-0.00015-9 · Cited by 2
Synthesis and evaluation of 4,6-disubstituted pyrimidines as CNS penetrant pan-muscarinic antagonists with a novel chemotype
Bender, A. M., Weiner, R. L., Luscombe, V. B., Cho, H. P., Niswender, C. M., Engers, D. W., Bridges, T. M., Conn, P. J., & Lindsley, C. W. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.04.009 · Cited by 2
Self-citation
Allosteric modulators restore orthosteric agonist binding to mutated CB1 receptors
Dopart, R., & Kendall, D. A. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13193 · Cited by 2
The computational modeling of allosteric modulation of metabotropic glutamate receptors
Pérez‐Benito, L., del Torrent, C. L., Pardo, L., & Tresadern, G. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.02.004 · Cited by 2
6-Aryl-quinazolines as novel GABAB receptor positive allosteric modulators
Huszár, J., Petró, J. L., Hadady, Z., Bobok, A. Á., Sághy, K., Halász, A. S., Hornyánszky, G., Román, V., Greiner, I., & Éles, J. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128714 · Cited by 2
Sonochemical synthesis and biological evaluation of isoquinolin-1(2H)-one/isoindolin-1-one derivatives: Discovery of a positive ago-allosteric modulator (PAAM) of 5HT2CR
Kumar, J. S., Naimisha, R., Thirupataiah, B., Reddy, G. S., Bung, N., Roy, A., Bulusu, G., Mishra, A., Yadav, P. N., Misra, P., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106202 · Cited by 2
Evidence for heterodimerization and functional interaction of the urotensin II and the angiotensin II type 1 receptors
Nassour, H., Pétrin, D., Devost, D., Billard, É., Sleno, R., Hébert, T. E., & Chatenet, D. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111056 · Cited by 2
Therapeutic and Diagnostic Agents for Parkinson's Disease
Booth, R. G., Neumeyer, J. L., & Baldessarini, R. J. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc105.pub2 · Cited by 2
Design, synthesis, and characterization of [ 18 F]mG2P026 as a high contrast PET imaging ligand for metabotropic glutamate receptor 2Preprint
Yuan, G., Dhaynaut, M., Guehl, N. J., Afshar, S., Huynh, D., Moon, S.-H., Iyengar, S., Kang, H. J., Ondrechen, M. J., Fakhri, G. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.29.450249 · Cited by 2
Ligand Docking Methods to Recognize Allosteric Inhibitors for G-protein Coupled ReceptorsPreprint
Krishnan, H., Jayashree, S., Tiwari, V. R., Vishwanath, S., & Sowdhamini, R. (2021) · Research Square · doi:10.21203/rs.3.rs-218684/v1 · Cited by 2
Profiling of HCAR1 signaling reveals Gα i/o and Gα s activation without β-arrestin recruitment and the discovery of an allosteric agonistPreprint
Lind, S., Wright, S. C., Gvozdenović, E., Nilsson, K., Granberg, K. L., Bouvier, M., & Johansson, L. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.02.651384 · Cited by 2
Structural development of 1,2,3,4-tetrahydroisoquinoline-type positive allosteric modulators of prostacyclin receptor (IPPAMs) to improve metabolic stability, and investigation of metabolic fate
Miyachi, H., Suzuki, T., Imamura, R. M., Nagano, T., & Okabe, T. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.040 · Cited by 1
G-quadruplex-regulated exonuclease cooperative hydrolysis signal transduction strategy for processing molecular temporal information
Zhou, F., Liu, X., Xu, S., Cui, S., Zhang, X., Man, H., & Wang, B. (2024) · New Journal of Chemistry · doi:10.1039/d4nj03867c · Cited by 1
Effect of the mGlu2 receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmoset
Shaqfah, J., Bédard, D., Nuara, S. G., Gourdon, J. C., Hamadjida, A., Gaudette, F., Beaudry, F., & Huot, P. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178031 · Cited by 1
Artificial intelligence in GPCR drug discovery: A paradigm shift in computational pharmacology
Vinter, A., & Grgičević, I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00047-9 · Cited by 1
Kinetic assays to characterize fluorescent ligand binding to muscarinic acetylcholine M1 receptor
Laasfeld, T., Bláhovcová, H., Hollo, K., Veikšina, S., Rinken, A., & Allikalt, A. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117911 · Cited by 1
An Integrative Biophysical and Computational Workflow Uncovers New Allosteric Sites and Modulators of the Human A 2A Adenosine Receptor
Prudent, R., Ray, A. P., Thakur, N., Moréno, A., Tandarić, T., Kanonenberg, K., Lemoine, H., Forcellini, E., Cecon, E., Roche, D., et al. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00003 · Cited by 1
Recent Advances in Dopamine Receptor Ligands as Chemical Biology Tools
Dorogan, M., Krishna, N. H., Patra, S., & Harding, W. W. (2026) · ACS Omega · doi:10.1021/acsomega.6c01474 · Cited by 1
Synthesis and systematic evaluation of four stereoisomers of BMS compound A enabled by a diastereoselective cyclopropanation on a chiral ketal intermediate
Wang, F., Hanson, J. N., Dimova, S. T., Rayadurgam, J., Fulton, C. J., Moritz, A. E., Nilson, A. N., Hearne, W. A., Chen, C., Gumpper, R. H., et al. (2026) · RSC Advances · doi:10.1039/d6ra02434c · Cited by 1
Allosteric modulation of ionotropic and G protein-coupled receptors in Alzheimer's disease: A neuroprotective strategy and therapeutic implications
Fereidouni, A., Nematollahi, S., Mathew, K. T., Favennec, V., Liceran, L., Aldenhoff-Kelly, C., Valdivieso, M. A., Trent, S., & Moradikor, N. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154063 · Cited by 1
GPCRs: Past, present, and future
Vroling, B., Bywater, R. P., Oliveira, L., & Vriend, G. (2010) · Springer eBooks · doi:10.1007/978-3-7091-0045-5_14 · Cited by 1
Putting a dampener on inflammation
Kingwell, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3259 · Cited by 1
Structural Insights into Activation and Allosteric Modulation of G Protein-Coupled Receptors
Kruse, A. C. (2015) · NATO science for peace and security series. A, Chemistry and biology · doi:10.1007/978-94-017-9719-1_2 · Cited by 1
In Silico-Screening Approaches for Lead Generation: Identification of Novel Allosteric Modulators of Human-Erythrocyte Pyruvate Kinase
Tripathi, A., & Safo, M. K. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-334-9_19 · Cited by 1
Drug discovery
Miller, S. M., Moos, W. H., Munk, B. H., & Munk, S. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100625-2.00011-8 · Cited by 1
Allostery in oligomeric receptor models
Smith, G. D. (2019) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqz016 · Cited by 1
[DNA transformation activity of a human gastrocarcinoma cell line].
Lü, Y. Y., Lu, G., Xu, X.-L., Ee, Z., Miao, J., Li, H., Cai, H., Chen, S. M., Deng, G. R., & Liu, P. N. (1986) · PubMed · Cited by 1
A Novel Method to Estimate Levels of Receptors Using an Allosteric Modulator: Focus on Muscarinic M1 Receptor
Pavey, G., Snelleksz, M., & Dean, B. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3307-6_1 · Cited by 1
Metabotropic Glutamate Receptor Subtype 5 Positron-Emission-Tomography Radioligands as a Tool for Central Nervous System Drug Development: Between Progress and Setbacks
Dupont, A.-C., Arlicot, N., Vercouillie, J., Sérrière, S., Maïa, S., Bonnet‐Brilhault, F., & Ribeiro, M. J. (2023) · Pharmaceuticals · doi:10.3390/ph16081127 · Cited by 2
THE SEROTONIN 5-HT2ARECEPTOR AS AN EVOLVING NEUROTHERAPEUTIC TARGET
Bolinger, A. A., Anastasio, N. C., Cunningham, K. A., & Zhou, J. (2023) · Medicinal chemistry reviews · doi:10.1021/mc-2023-vol58.ch03 · Cited by 1
Update on mGlu4 modulator patents: 2017 to present
Rahman, F. I., Webster, T. M., & Hopkins, C. R. (2025) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2025.2467679 · Cited by 1
Change in expression of vesicular protein synapsin II by chronic treatment with D2 allosteric modulator PAOPA
Basu, D., Tian, Y., Hui, P., Bhandari, J., Johnson, R. L., & Mishra, R. K. (2015) · Peptides · doi:10.1016/j.peptides.2015.01.004 · Cited by 1
Première caractérisation d’un inhibiteur allostérique des récepteurs desfibroblast growth factors
Herbert, C., Alcouffe, C., & Bono, F. (2013) · médecine/sciences · doi:10.1051/medsci/20132910007 · Cited by 1
Paramagnetic NMR in Drug Discovery
Çetiner, E. C., & Schwalbe, H. (2018) · Royal Society of Chemistry eBooks · doi:10.1039/9781788013291-00258 · Cited by 1
Sialorphin Potentiates Effects of [Met5]Enkephalin without Toxicity by Action other than Peptidase Inhibition
Kan, T., Yoshikawa, M., Watanabe, M., Miura, M., Ito, K., Matsuda, M., Iwao, K., Kobayashi, H., Suzuki, T., & Suzuki, T. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.266080 · Cited by 1
Restoring Agonist Function at a Chemogenetically Modified M1Muscarinic Acetylcholine Receptor
Khajehali, E., Bradley, S. J., van der Westhuizen, E. T., Molloy, C., Valant, C., Finlayson, L. H., Lindsley, C. W., Sexton, P. M., Tobin, A. B., & Christopoulos, A. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00540 · Cited by 1
Self-citation
Technologies for Screening of mGlu Receptor Allosteric Modulators
Rodriguez, A. L., & Niswender, C. M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1107-4_1 · Cited by 1
Encounter Complexes Between the N-terminal of Neurotensin with the Extracellular Loop 2 of the Neurotensin Receptor 1 Steer Neurotensin to the Orthosteric Binding Pocket
Asadollahi, K., Rajput, S., Jameson, G. N. L., Scott, D. J., & Gooley, P. R. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168244 · Cited by 1
Screening and Drug Discovery
Davenport, E. A., & Ames, R. S. (2011) · doi:10.1002/9781118147177.ch13 · Cited by 1
GPCR-G protein fusions: Use in functional dimerization analysis
Milligan, G. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511760334.004 · Cited by 1
Special Issue on the Pharmacology and Medicinal Chemistry of Allosteric Modulators of Metabotropic Glutamate Receptors (mGluRs)
Lindsley, C. W. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200069d · Cited by 1
Self-citation
Role of prefrontal cortex and cholinergic modulation in attentional performance in rats
Fisher, B. M. (2017) · Apollo (University of Cambridge) · doi:10.17863/cam.21750 · Cited by 1
Receptor Targets in Drug Discovery
Duzic, E., Marino, M. J., & Williams, M. J. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc029.pub2 · Cited by 1
3D enantioselective descriptors for ligand-based computer-aided drug design
Sliwoski, G. R. (2012) · Cited by 1
Evaluating Novel Muscarinic Acetylcholine Receptor Potentiators for the Treatment of Cognitive Deficits in Schizophrenia
Grannan, M. D. (2016) · Cited by 1
The Cholinergic System
Abbas, S. F. (2019) · Chemical Biology of Neurodegeneration · doi:10.1002/9783527813421.ch4
Dissecting conformational rearrangements and allosteric modulation in metabotropic glutamate receptor activationPreprint
Lecat‐Guillet, N., Quast, R. B., Liu, H., Møller, T. C., Rovira, X., Soldevila, S., Lamarque, L., Trinquet, E., Liu, J., Pin, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.07.474531 · Cited by 1
News in brief
(2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2814 · Cited by 1
Special issue: Glutamate– physiology, pathology, therapy
Wierońska, J. M., & Stachowicz, K. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00670-w · Cited by 1
Extracellular Nanobody Screening using Conformationally Stable GPCRPreprint
Zhang, X., Gao, K., Nie, J., Meng, H., Sun, X., Zhao, J., & Liu, X. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.25.645380 · Cited by 1
Multiple Allosteric Sites Allow for Synergistic Enhancement of GPCR SignalingPreprint
Wang, K., Dimova, S. T., Hanson, J. N., Thakur, A., Xu, Y., Liu, Y.-F., Moritz, A. E., Goldberg, A., Xie, B., Rayadurgam, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.21.683604 · Cited by 1
Cryo-EM structures of brain-derived G protein-coupled receptorsPreprint
Wright, N. A., Chiu, Y.-T., Sakamoto, K., Koçak, D. D., Llorach, P., Fordyce, B. A., Hua, K., Huang, K. L., Scherrer, G., Lyons, S. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.01.715822 · Cited by 1
Predicting Drug Target Proteins and Their Properties
Bull, S. C. (2015) · Research Explorer (The University of Manchester) · Cited by 1
New Developments in Sweeteners
Servant, G., & Rosenberg, G. (2012) · doi:10.1002/9781118373941.ch17
Receptores de dopamina y heterómeros de receptores de dopamina en la modulación de la neurotransmisión
González‐Torres, S. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Characterizing the cognitive, behavioural, and mechanistic actions of novel allosteric modulator PAOPA for the treatment of schizophrenia
Bhandari, J. (2015) · MacSphere (McMaster University) · doi:10.71548/21752
Chemical Perspective on Neurotransmission and Drug Discovery for the Central Nervous System
Mailman, R. B., & Vrana, K. E. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc245
Class C receptor activation mechanisms illustrated by mGlu and GABAB receptors. A review.
Prézeau, L., Rondard, P., Goudet, C., Kniazeff, J., & Pin, J. (2011) · Flavour and Fragrance Journal · doi:10.1002/ffj.2044
Allosteric Proteins and Drug Discovery
Bell, J. E., & Bell, J. K. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc028.pub2
Participación de los receptores muscarínicos en el efecto del β - amiloide (25-35) sobre las neuronas piramidales de la región CA3 del hipocampo. Estudio Electrofisiológico
Castro, A. S. (2011) · Gredos (University of Salamanca) · doi:10.14201/gredos.110826
G Protein‐Coupled Receptors
Dickenson, J. M., Freeman, F., Mills, C. L., Sivasubramaniam, S., & Thode, C. (2012) · Molecular Pharmacology · doi:10.1002/9781118451908.ch3
The activation of the glucagon-like peptide-1 (GLP-1) receptor by peptide and non-peptide ligands
Wishart, C. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Allosteric Modulators: Potential Treatment for Schizophrenia
Daya, R. P. (2012) · The Meducator · doi:10.15173/m.v1i20.786
The Structural Basis of Gβ5-RGS7 Interaction with the Muscarinic M3 Receptor and Implications for its Role in Functional Pathway Selectivity
Karpinsky‐Semper, D. (2014)
A Tale of Two Protein Switches: Engineering, Characterizing, and Understanding a Novel and a Natural Switch
Price, J. V. (2013)
A new look at membrane protein binding
Lunn, C. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1820
Inhibitory G-protein Modulation of CNS Excitability.
Kehrl, J. H. (2014) · Deep Blue (University of Michigan)
M3-muscarinic receptor signaling pathways: therapeutic targets for diabetes?
Kong, K. C., & Tobin, A. B. (2011) · Diabetes Management · doi:10.2217/dmt.11.2
ASelectiveAllostericPotentiatoroftheM 1 Muscarinic AcetylcholineReceptorIncreasesActivityofMedial PrefrontalCorticalNeuronsandRestoresImpairments inReversalLearning
Brady, A., Jones, P. J., Davis, A. A., PhillipKennedy, J., Jadhav, S. B., & Menon, U. N. (2009)
G-Protein-Dependent and -Independent Signaling Pathways and their Impact on Cardiac Function Compartmentalization of b-Adrenergic Signals in Cardiomyocytes G-Protein-Coupled Receptor Kinases (GRK) as Therapeutic Targets in Cardiovascular Disease Regulators of G-Protein Signaling in the Heart and Their Potential as Therapeutic Targets
DeWire, S. M., & Violin, J. D. (2011)
Allostery: Abl Kinase And Trubind? Back-Scattering Interferometry
Lavieri, R. R. (2015) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.32649
Orthosteric and allosteric probes for cannabinoid receptors
Tichkule, R. B. (2012) · doi:10.17760/d20002784
Assessing allosteric ligand-receptor interactions
Vranesic, I.-T., & Hoyer, D. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511760334.014
Fragment-Based Discovery of Allosteric Ligands
Howard, S. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620938-00153
Drugs that Target the Glutamate Synapse: Implications for the Glutamate Hypothesis of Schizophrenia
Mielnik, C. A., & Ramsey, A. J. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622499-00115
Allosteric Modulation of the Mu Opioid Receptor.
Livingston, K. E. (2016) · Deep Blue (University of Michigan)
Extracellular and Intracellular Regulation of G Protein-Coupled Receptor Signaling
Rittiner, J. E. (2013) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/3qh6-tg14
Structure and evolution of protein allosteric sites
Panjkovich, A. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
M1 and M4 muscarinic acetylcholine receptor regulation of neurotransmission and cell excitability in rodent hippocampus and prefrontal cortex.
Shirey-Rice, J. K. (2010)
Characterisation of antagonist binding sites on chemokine receptor CCR4
Viney, J. M. (2012) · Spiral (Imperial College London) · doi:10.25560/11128
Allosteric Control of Beta2-adrenergic Receptor Function.
Mahoney, J. P. (2016) · Deep Blue (University of Michigan)
Machine learning algorithms for prediction of biological activity and chemical properties
Mueller, R. (2011)
Positive Allosteric Modulators of G-Protein-Coupled Receptors that Act via Covalent Mechanisms of Action
Nolte, W. M., & Carpino, P. A. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782629276-00271
Muscarinic Receptors Allosteric Modulation
Melancon, B. J., & Hopkins, C. R. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782629276-00175
mGlu2 Receptor Positive Allosteric Modulators
Trabanco, A. A., Cid, J. M., & Tresadern, G. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782629276-00156
Oligomers of G proteins identified in live CHO cells and extracts of Sf9 cells
Ji, H. (2015) · TSpace (University of Toronto)
D1 AND D2 DOPAMINE RECEPTOR BIASED AND HETEROMERIC SIGNALING: IMPLICATIONS FOR PROTEIN CONFORMATIONAL FLUIDITY
Chun, L. S. (2015)
G-protein coupled receptor mediated signaling pathways in chemoresistant melanoma and ovarian cancer
Altman, M. K. (2014)
Targeting muscarinic receptor subtypes as a therapeutic approach in dystonia and Parkinson's disease
Klisko, D. (2017) · Research Portal (King's College London)
Receptors: Functional Assays
Lavreysen, H., & Atack, J. R. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_208-2
Allosteric Modulator of Mas-Related G-Protein Coupled Receptor X1 (MrgprX1) Inhibits Persistent Pain
Li, Z. (2016)
Arterial Function and Structure in Experimental Hypertension
Lemkens (2018) · doi:10.26481/dis.20181128pl
G protein-coupled receptor allosteric modulators
Willard, F. S., & Wainscott, D. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00014-3
Modulation of Cannabinoid Receptor Activity by Allosteric Modulators, Inverse Agonists and Receptor Binding Partners
Mahmoud, M. M. (2015) · OpenCommons at University of Connecticut (University of Connecticut)
Novel allosteric modulators of the M1 muscarinic acetylcholine receptor provide new insights into M1-dependent synaptic plasticity and receptor signaling
Moran, S. P. (2019)
Optimization and characterization of muscarinic acetylcholine receptor M4 positive allosteric modulators
Le, U. (2011)
Allosterism and Drug Discovery
Bell, J. E., & Bell, J. K. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc299
Recent Developments in Treating Cognitive Impairment Associated with SchizophreniaPreprint
Bittner, R. A., Barnes-Scheufler, C. V., Hettwer, M. D., Reif, A., & Qubad, M. (2021) · Preprints.org · doi:10.20944/preprints202105.0257.v1

Authors: Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W.
Affiliations: Monash University (AU)
Vanderbilt University (US)
ORCID: Christopoulos, Arthur
Lindsley, Craig W.
Venue: Nature Reviews Drug Discovery
Publisher: Springer Science and Business Media LLC
Published: 2009-01
Volume: 8
Issue: 1
Pages: 41-54
ISSN: 1474-1776 (ISSN-L)
1474-1784
DOI: 10.1038/nrd2760
PMC: PMC2907734
OpenAlex: W2003736358
Cited by: 1,063
References: 139
Citations by year: 2026: 30 · 2025: 46 · 2024: 37 · 2023: 25 · 2022: 48 · 2021: 51 · 2020: 44 · 2019: 58 · 2018: 57 · 2017: 68 · 2016: 64 · 2015: 67 · 2014: 69 · 2013: 80 · 2012: 75
FWCI: 6.60
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Drug Discovery (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Mental Health (R01MH073676, R01MH074953, R01MH062646)
National Institute on Drug Abuse (R01DA023926)
National Institute of Neurological Disorders and Stroke (R01NS031373)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: G protein-coupled receptors, allosteric modulators, allosteric site, orthosteric ligands, mental illness, neurological disorders, CNS drug discovery, receptor selectivity, novel therapeutic agents
MeSH terms: Allosteric Regulation, Animals, Central Nervous System Diseases, Drug Evaluation, Preclinical, Humans, Ligands, Drug Design, Receptors, G-Protein-Coupled

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks